New patent expiration for Aveo Pharms drug FOTIVDA – DrugPatentWatch
Annual Drug Patent Expiration for FOTIVDA
Fotivda is a drug marketed by Aveo Pharms and included in one NDA. It is available from a single supplier. There are three patents protecting this drug.
This drug has fifty-one patent family members in twenty-six countries.
The generic ingredient in FOTIVDA is tivozanib hydrochloride. One registered supplier for this compound. Additional details are available on the tivozanib hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published on expiration of new patent for Aveo Pharms drug FOTIVDA